These are Gilead scientists. They’re not just experts in oncology, virology and inflammation: They’re relentless thinkers with an unwavering commitment to discovery. Here, in our labs, every intricate step, reset and do-over plays a critical role in helping set and achieve bold ambitions in our fight against the world’s most devastating diseases. #GileadLife | Gilead Sciences

Take a spin through the latest in Gilead’s science and innovation in our new series, The Centrifuge Sessions. Today we sit down with Barry Crittenden, Executive Director of Clinical Development, to discuss how Gilead is helping make an impact for people living with primary biliary cholangitis (PBC), a rare autoimmune disease that affects the liver. | Gilead Sciences

At Gilead, patients are at the heart of everything we do – and we’re focused on developing and delivering innovative therapies across virology, oncology and inflammatory diseases. As we gather today for our annual Science Day, learn why our researchers are passionate about the work they do. #GileadLife | Gilead Sciences